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● Introduction to issues of race as a risk factor 
(VBAC Calculator)
○ Race is a social construct, not genetic
○ Unclear causality of observed disparities
○ Possible medical consequences for patients
○ Patient and community trust/mistrust
● Evaluating the VBAC Calculator
● Theory/Research into Causes of Health Disparities
○ Ecosocial Theory
○ Racism as opposed to race
● Evaluating race use in eGFR algorithms
○ Evidence 
○ Causal mechanism
○ Effect on health equity/patients
● Next steps
Case: 
Z.P. was a 32yo G6P5005 at 36wks
No complaints but desiring a TOLAC. 
She had had 4 previous SVDs, but most 
recently had a c-section for non-
reassuring FHTs. 
We did a TOLAC Informed Consent 
discussion and forms.
Case: 
Z.P. was a 32yo G6P5005 at 36wks
ZP is African-American and Hispanic.
Her VBAC percents:
As Hispanic: 52.4%
As African American: 52.7%
As neither: 68.5%
Race as a risk factor
Issue 1:
● Race is a social construct, not biological 
category
→ 90-95% of genetic variation “occurs 
within, not among, continental 
populations” (Cooper, et al.)
tufts.edu
Race as a risk factor
Issue 2:
● The unclear etiology of disparities
→ Is race the most appropriate 
grouping or just convenient?
newscientist.com
Race as a risk factor
Issue 3:
● The consequences of differentiating healthcare 
based on race
○ For the patient
○ For health disparities
2018 C-section data from CDC 
Graph from birthbythenumbers.org/
Race as a risk factor
Issue 4:
● The ugly legacy of race in medicine means 
that the use of racial categories has 
implications for patient/community trust,





Race was “one of the factors that was most predictive… 
race/ethnicity is a socially determined variable. There’s no 
reason to think that those differences are biologically based.”
magazine.nm.org




Do not ignore race.
“Distinguish between the use of race in descriptive statistics, where it plays a 
vital role in epidemiologic analyses, and in prescriptive clinical guidelines, 
where it can exacerbate inequities.”
massgeneral.org
Darshali A. Vyas. (now an Internist at Massachusetts General Hospital), Eisenstein LG, and Jones DS. “Hidden in Plain 
Sight-- Reconsidering the Use of Race Correction in Clinical Algorithms.” NEJM. August 2020.
“Defensible empirical logic” 
is not enough.
Proposes three questions for clinical algorithms:
1) Is the need for race correction based on robust evidence?
2) Is there a “plausible causal mechanism” for the racial difference?
3) Would the race correction relieve or exacerbate health equities?
massgeneral.org
Vyas DA, Eisenstein LG, and Jones DS. “Hidden in Plain Sight-- Reconsidering the Use of Race Correction in Clinical 
Algorithms.” NEJM. August 2020.




3) Effect on health 
equity?








3) Effect on health 
equity?
● VBAC Calculator
● Colon Cancer Screening Guidelines
● ASCVD Score
● Heart Failure Risk Score
● Osteoporosis Risk Estimation (SCORE)
● FRAX Score
● STONE Score for ureteral stones
● Pediatric UTI Calculator
● USPSTF STI Screening Recommendations
● Pulmonary Function Tests
● eGFR
● Medication selection
… and many more algorithms and guidelines 
in primary and specialty care
Theory and Research 
on Racial Health Disparities
Ecosocial Theory
“People literally embody, biologically, their lived experience, in societal and 
ecological context, thereby creating population patterns of health and disease.”
“At issue are socially patterned exposure-induced pathogenic pathways, 
mediated by physiology, behavior, and gene expression…”
Nancy Krieger (an epidemiologist at the Harvard School of Public Health). “Methods for the Scientific Study of 
Discrimination and Health: An Ecosocial Approach.” Amer J of Public Health. May 2012.
racialhealthequity.org
Ecosocial Theory
“The more prevalent the health 
outcome, the greater the absolute 
burden… on those with less power and 
fewer resources, because they 
constitute the majority of the 
population; a corollary is that for more 
rare or infrequent (nonendemic) 
diseases, it cannot be presumed, in 
advance, whether social inequalities in 
the outcome exist, and, if they do, the 
direction of the gradient.”
Core Proposition #4:
Common diseases are more likely to have 
exogenous influences implicated in population 
disparities. 
Rare diseases not so much. 
racialhealthequity.org
Krieger N. “Methods for the Scientific Study of Discrimination and Health: An Ecosocial Approach.” Amer J of Public Health. May 2012.
Ecosocial causality beyond SES
February 2020, at the sixth annual 
University of Pennsylvania Martin 
Luther King Jr. Health Equity 
Symposium
Leandris Liburd, PhD, MPH, MA 
is the Associate Director for the 
Office of Minority Health and 
Health Equity at the CDC
ldi.upenn.edu
Discussing the complexity of social determinants as a major concern for the 
CDC Office of Minority Health and Health Equity:
The rate of maternal mortality for Black women 
“with at least a college degree… was five times as 
high as that of white women with similar education.”





“an overview of the evidence linking the primary 
domains of racism—structural racism, cultural racism, 
and individual-level discrimination—to mental and 
physical health outcomes”
David R. Williams, Lawrence JA, Davis BA. “Racism and Health: 
Evidence and needed research.” Annu Rev Public Health 2019;40:105–
25.
TED TALK: How racism makes us sick
UNNATURAL CAUSES… is inequality 
making us sick?
Berkeley medical 
students wrote a 
comprehensive 




The gold standard for measuring GFR is 125I iothalamate clearance, 
but this is clinically impractical. 
Instead, we estimate GFR using endogenous creatinine or cystatin C.
● 1973 Cockcroft-Gault Equation (for Cr Clearance)
● 1999 Modification of Diet in Renal Disease (MDRD) 
Suggested to only report eGFRs below 60mL/min/1.73 m2






“The use of kidney function estimating equations that include race as a variable 
cause problems for transparency and unduly restrict access to care in some 
cases, yet offer only modest benefits to precision.”
pennmedicine.org
Nwamaka Denise Eneanya (nephrologist at UPenn), Yang W, Reese PP. Reconsidering the consequences of using race 
to estimate kidney function. JAMA. 2019
pennmedicine.org
Eneanya ND, Yang W, Reese PP. Reconsidering the consequences of using race to estimate kidney function. JAMA. 
2019
Challenging eGFR
Using race to guide clinical care is justified only if:
1) the use confers substantial benefit 
2) the benefit cannot be achieved through other feasible approaches
3) patients who reject race categorization are accommodated fairly
4) the use of race is transparent
pennmedicine.org
clipart-library.com
Eneanya ND, Yang W, Reese PP. Reconsidering the consequences of using race to estimate kidney function. JAMA. 
2019
Naomi Nkinsi, an MD/MPH student 
in the University of Washington 
Anti-Racism Action Committee 
medicine.uw.edu/
“The use of race in the biomedical environment is an 
imprecise variable and does not meet the scientific 
rigor UW Medicine expects of diagnostic tools.”








175 x (SCr)-1.154 x (age)-0.203
x 0.742 [if female] x 1.212 [if AA]




3) Effect on health 
equity?
Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D. A more accurate method to estimate 
glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in 
Renal Disease Study Group. Ann Intern Med. 1999;130(6):461-470.




3) Effect on health 
equity?
AA-correction factor was derived 
from the AASK trial in 2000:
1,094 participants
29% current smokers (23%)
41% did not graduate HS (25%)
48% reported income <$15k
(19% declined to report income)
Norris KC, Greene T, Kopple J, et al.  Baseline predictors of renal disease progression in the African 
American Study of Hypertension and Kidney Disease. J Am Soc Nephrol. 2006;17(10): 2928–2936.








175 x (SCr)-1.154 x (age)-0.203
x 0.742 [if female] x 1.212 [if AA]
Among other things, study used Bioelectrical Impedance Analysis to see if 
higher SCr among Black HD patients could be explained by muscle mass.








175 x (SCr)-1.154 x (age)-0.203
x 0.742 [if female] x 1.212 [if AA]
Challenging eGFR
“The use of kidney function estimating equations that include race as a variable 
cause problems for transparency and unduly restrict access to care in some 
cases, yet offer only modest benefits to precision.”
pennmedicine.org






Responding to Eneanya et al.
“Eliminating race… may have unintended consequences in 
African American individuals, such as inappropriate early transplant or 
dialysis initiation, overdiagnosis of CKD, overestimation of the association of the 
risk of adverse outcomes with reduced GFR, inadequate dosing of drugs… and 
limited access to tests (eg, some imaging procedures) and treatments… 
including living kidney donation. Better methods are needed to improve accuracy 
of GFR assessment without requiring specification of race.”
tuftsmedicalcenter.org
Levey AS, Tighiouart H, Titan SM, Inker LA. Estimation of glomerular filtration rate with vs without including patient race. JAMA Intern Med. 2020;180(5):793-795.
tuftsmedicalcenter.org
Levey AS, Titan SM, Powe NR, Coresh J, Inker LA. Kidney disease, race, and GFR estimation. Clin J Am Soc Nephrol. 2020;15(8):1203-1212.
(and in JAMA Internal Medicine 2020)
A team at TJUH led by 
Dr. Omar Maarouf and Dr. Traci Trice
is working to eliminate the AA-
correction variable
Moving forward
Until we have a better method 
for evaluating renal function, 
what should we do?
linkedIn
jefferson.edu
The result is an eGFR algorithm developed from a dataset that specifically 
excluded participants who identified as African American.
If the equation was based on the African American study participants with a correction factor 
for non-AA patients… would we be eliminating this correction factor?
eGFR =
212 x (SCr)-1.154 x (age)-0.203
x 0.742 [if female] x 0.825 [if not AA]
eGFR = 
212 x (SCr)-1.154 x (age)-0.203
x 0.742 [if female] x 0.825 [if not AA]
For a 50 y.o. white cisman with Cr=1.3, eGFR = 58, 
but, without the race correction variable, eGFR= 71.
Recent studies have found no increased eGFR 
accuracy with the AA-correction factor in Brazil, 
South Africa, the Democratic Republic of the 
Congo, Ghana, and Côte d'Ivoire. 
Bukabau JB, Sumaili EK, Cavalier E, et al. Performance of glomerular filtration rate estimation equations in Congolese healthy adults: The 
inopportunity of the ethnic correction. PLoS One. 2018;13(3):e0193384.
Bukabau JB, Yayo E, Gnionsahe A, et al. Performance of creatinine- or cystatin C–based equations to estimate glomerular filtration rate in 
sub-Saharan African populations. Kidney International. 2019;95. 1181–1189.
Madala ND, Nkwanyana N, Dubula T, Naiker IP. Predictive performance of eGFR equations in South Africans of African and Indian ancestry 
compared with ⁹⁹mTc-DTPA imaging. Int Urol Nephrol. 2012 Jun;44(3):847-55.
Zanocco JA, Nishida SK, Passos MT, et al. Race adjustment for estimating glomerular filtration rate is not always necessary. Nephron Extra. 
2012;2(1):293-302.
newsweek.com
Alternatively, we could reaggregate 
the data and develop a new algorithm 
without a race variable, instead of 
defaulting to the non-African 
American algorithm.
For eGFR specifically:
● GFR should be considered a range and not a numeric value
● Rate of change in eGFR should be considered when values are low
● Race correlations are complex and should not be systematized into our 
eGFR algorithms
● Critically evaluate any use of race in medicine
○ Evidence 
○ Causal mechanism
○ Effect on health equity/patients
● Race is not genetic and is a crude proxy for other 
factors (investigate them)
● Be transparent with patients and allow them to 
self-identify and share decision making
● Be cautious not to ignore race altogether
Take-Home Points
In the future, how will you 
use the VBAC calculator, 
interpret eGFR values, or 
counsel patients 
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